Direct activation of TERT transcription by c-MYC
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of hTERT transcription is driven by the c-Myc oncogene forming a heterodimer, c-Myc/Max, that binds to E-box sequences in the promoter of hTERT [248,249,250]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [248]
In the citing paper
“The TERT promoter is controlled in some contexts by the c-Myc oncogene, which recognizes E-boxes within the promoter (56,57), and by estrogen receptor and Sp1 (58).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [56]
In the citing paper
“There are at least five GC-boxes within the core promoter of hTERT, proven by EMSA to bind Sp1.(22) Introduction of mutations in these GC-boxes significantly decreased the transcriptional activity of the promoter, while overexpression of Sp1 in cells that contain relatively low levels of endogenous Sp1 enhanced the promoter activity.(17)”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
In the citing paper
“In fact, several groups confirmed that c-Myc binds to E-boxes on the hTERT promoter and activates the transcription (15)(16)(17)(18)(19) which established the scenario that c-Myc is a key regulator of hTERT transcription during carcinogenesis.”
From Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [17]
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“Contrary to early reports suggesting a specific association between telomerase activity and cell immortalization or transformatio”
BackgroundExtension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Self-citationMeyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269
Self-citationLuciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., & Evan, G. I. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.10.1686 · Cited by 781
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity
Ayer, D. E., Kretzner, L., & Eisenman, R. N. (1993) · Cell · doi:10.1016/0092-8674(93)90661-9 · Cited by 703
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653
Cited by
Items 501–600 of 911
Stewart, R., Yang, C., Anyfantis, G., Przyborski, S. A., Hole, N., Strachan, T., Stojković, M., Keith, W. N., Armstrong, L., & Lako, M. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.4.505 · Cited by 27
Zhang, Y., Chen, L., Yang, S., & Fang, D.-C. (2012) · Medical Science Monitor · doi:10.12659/msm.882192 · Cited by 28
Yang, S., Fang, D.-C., Yang, J., Chen, L., Luo, Y., & Liang, G. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282b71f0d · Cited by 25
Bu, D.-X., Johansson, M. E., Ren, J., Xu, D., Johnson, F. B., Edfeldt, K., & Yan, Z.-Q. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213074 · Cited by 25
Richards, L. A., Kumari, A., Knezevic, K., Thoms, J. A. I., von Jonquières, G., Napier, C. E., Ali, Z., O’Brien, R., Marks-Bluth, J., Maritz, M. F., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.215699 · Cited by 26
Deng, J., Yu, P., Zhang, Z., Zhang, J., Zhewen, S., Cai, M., Yuan, H., Liang, H., & Yang, F. (2019) · Metallomics · doi:10.1039/c9mt00193j · Cited by 25
McKelvey, B. A., Gilpatrick, T., Wang, Y., Timp, W., Umbricht, C. B., & Zeiger, M. A. (2020) · Thyroid · doi:10.1089/thy.2020.0055 · Cited by 25
Huang, J. J., Lin, M. C. M., Bai, Y. X., Jing, D. D., Wong, B. C. Y., Han, S. W., Lin, J., Xu, B., Huang, C., & Kung, H. (2002) · PubMed · Cited by 28
The molecular basis of ageing in stem cells
Tam, W. L., Ang, Y.-S., & Lim, B. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.11.020 · Cited by 32
Mochida, A., Gotoh, E., Senpuku, H., Harada, S., Kitamura, R., Takahashi, T., & Yanagi, K. (2005) · Archives of Virology · doi:10.1007/s00705-005-0557-2 · Cited by 25
Telomerase in Breast Cancer: A Critical Evaluation
Baykal, A., Rosen, D. G., Zhou, C., Liu, J., & Şahin, A. A. (2004) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000138145.19258.64 · Cited by 29
Zhou, F., Guo, C., Wang, L., Zhang, G., Wang, J., Chen, W., Cui, K., Tan, Y., & Zhou, Z. (2023) · Toxics · doi:10.3390/toxics11050448 · Cited by 24
Cheng, D., Wang, S., Jia, W., Zhao, Y., Zhang, F., Kang, J., & Zhu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-16764-w · Cited by 27
Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics
Smith‐Sonneborn, J. (2019) · Current Aging Science · doi:10.2174/1874609812666190620124324 · Cited by 25
Huang, M., Zeki, J. C., Sumarsono, N., Coles, G. L., Taylor, J. S., Danzer, E., Bruzoni, M., Hazard, F. K., Lacayo, N. J., Sakamoto, K. M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2560 · Cited by 24
Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action
Sun, J., Zhao, M., Jia, P., Lily, W., Wu, Y., Carissa, I., Zhou, Y., Bowton, E., Roden, D. M., Denny, J. C., et al. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004202 · Cited by 27
Targeted gene therapy for breast cancer with truncated Bid
Kazhdan, I., Long, L. M., Montellano, R., Cavazos, D., & Marciniak, R. A. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700867 · Cited by 24
Matte, M. Y. A.-D., Cheng, J. Q., & Kruk, P. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5231 · Cited by 27
Li, H., Pinto, A. R., Duan, W., Li, J., Toh, B., & Liu, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03439.x · Cited by 24
Kirch, H.-C., Ruschen, S., Brockmann, D., Esche, H., Horikawa, I., Barrett, J. C., Opalka, B., & Hengge, U. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205965 · Cited by 24
Jia, W., Wang, S., Horner, J. W., Wang, N., Wang, H., Gunther, E. J., DePinho, R. A., & Zhu, J. (2011) · The FASEB Journal · doi:10.1096/fj.10-173989 · Cited by 23
Wang, S., Hu, C., & Zhu, J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0456 · Cited by 23
Gupta, R. K., & Prasad, S. K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9287-y · Cited by 23
Kim, M.-O., Moon, D., Kang, S.-H., Heo, M.-S., Choi, Y. H., Jung, J. H., Lee, J.-D., & Kim, G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.08.030 · Cited by 24
Early growth response‐1 mediates downregulation of telomerase in cervical cancer
Akutagawa, O., Nishi, H., Kyo, S., Terauchi, F., Yamazawa, K., Higuma, C., Inoue, M., & Isaka, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00835.x · Cited by 23
Barker, K. S., Khayat, M. F., Miller, N. W., Wilson, M., Clem, L. W., & Bengtén, E. (2002) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00049-0 · Cited by 23
Ser326Cys polymorphism inhOGG1 gene and risk of esophageal cancer in a Chinese population
Xing, D.-Y., Tan, W., Song, N., & Lin, D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010520)95:3<140::aid-ijc1024>3.0.co;2-2 · Cited by 161
Uchino, J., Takayama, K., Harada, A., Kawakami, Y., Inoue, H., Curiel, D. T., & Nakanishi, Y. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700838 · Cited by 23
Kumari, A., Srinivasan, R., & Wig, J. D. (2009) · Pancreatology · doi:10.1159/000212094 · Cited by 22
Chen, S., Yang, Z., Zhang, Y., Qiao, Y., Cui, B., Zhang, Y., & Kong, B. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-40 · Cited by 22
Zheng, L., Suzuki, H., Nakajo, Y., Nakano, A., & Kato, M. (2017) · Cancer Science · doi:10.1111/cas.13466 · Cited by 24
Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige
Natua, S., Ashok, C., & Shukla, S. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03727-0 · Cited by 24
Expression profile of significant immortalization genes in colon cancer
Witkowska (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000348 · Cited by 22
Glasspool, R. M., Burns, S., Hoare, S. F., Svensson, C., & Keith, W. N. (2005) · Neoplasia · doi:10.1593/neo.04766 · Cited by 24
Multistep regulation of telomerase during differentiation of HL60 cells
Yamada, O., Ozaki, K., Nakatake, M., Akiyama, M., Kawauchi, K., & Matsuoka, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1207848 · Cited by 22
Differential activity of conditional MYC and its variant MYC-S in human mortal fibroblasts
Hirst, S. K., & Grandori, C. (2000) · Oncogene · doi:10.1038/sj.onc.1203904 · Cited by 28
Self-citationThe Involvement of Human Papilloma Virus in Gastrointestinal Cancers
Baj, J., Forma, A., Dudek, I., Chilimoniuk, Z., Dobosz, M., Dobrzyński, M., Teresiński, G., Buszewicz, G., Flieger, J., & Portincasa, P. (2022) · Cancers · doi:10.3390/cancers14112607 · Cited by 23
Swanberg, S. E., & Delany, M. E. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.03.022 · Cited by 23
PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma
Zhou, X., Zhu, H., & Lu, J. (2014) · Pathology - Research and Practice · doi:10.1016/j.prp.2014.11.016 · Cited by 22
Histone deacetylase inhibition as an anticancer telomerase‐targeting strategy
Rahman, R., & Grundy, R. G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26241 · Cited by 21
Elkady, A. I. (2012) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb12.1346 · Cited by 21
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes
Bazarov, A. V., Hines, W. C., Mukhopadhyay, R., Beliveau, A., Melodyev, S., Zaslavsky, Y., & Yaswen, P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9856 · Cited by 21
Crisostomo, R. H., Fernandez, J. A., & Cáceres, W. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.06.010 · Cited by 21
Song, J.-S. (2005) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.69.56 · Cited by 21
E2F1 acts as a negative feedback regulator of c-Myc-induced hTERT transcription during tumorigenesis
Zhang, Y., Zhang, A., Shen, C., Zhang, B., RAO, Z., Wang, R., Yang, S., Ning, S., Mao, G.-P., & Fang, D.-C. (2014) · Oncology Reports · doi:10.3892/or.2014.3287 · Cited by 26
Interferon-α repressed telomerase along with G1-accumulation of Daudi cells
Akiyama, M., Iwase, S., Horiguchi‐Yamada, J., Saito, S., Furukawa, Y., Yamada, O., Mizoguchi, H., Ohno, T., & Yamada, H. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00109-3 · Cited by 21
Telomerase: a potential therapeutic target for cancer
Fletcher, T. M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.457 · Cited by 21
Elkak, A., Meligonis, G., Salhab, M., Mitchell, B., Blake, J., Newbold, R. F., & Mokbel, K. (2005) · Journal of Carcinogenesis · doi:10.1186/1477-3163-4-17 · Cited by 23
Szutorisz, H., Lingner, J., Cuthbert, A. P., Trott, D. A., Newbold, R. F., & Nabholz, M. (2003) · PubMed · Cited by 21
Self-citationCheng, D., Zhao, Y., Wang, S., Jia, W., Kang, J., & Zhu, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.662221 · Cited by 20
A critical review on induced totipotent stem cells: Types and methods
Ghazimoradi, M. H., Khalafizadeh, A., & Babashah, S. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102857 · Cited by 20
Clonal inactivation of TERT impairs stem cell competition
Hasegawa, K., Zhao, Y., Garbuzov, A., Corces, M. R., Neuhöfer, P., Gillespie, V. M., Cheung, P., Belk, J. A., Huang, Y., Wei, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07700-w · Cited by 20
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness
Robinson, N. J., Morrison-Smith, C. D., Gooding, A. J., Schiemann, B. J., Jackson, M. W., Taylor, D. J., & Schiemann, W. P. (2020) · Life Science Alliance · doi:10.26508/lsa.201900427 · Cited by 20
Li, S., Khan, M. H., Wang, X., Cai, M., Zhang, J., Jiang, M., Zhang, Z., Wen, X., Liang, H., & Yang, F. (2020) · Dalton Transactions · doi:10.1039/d0dt02266g · Cited by 21
PinX1 Inhibits Telomerase Activity in Gastric Cancer Cells Through Mad1/c-Myc Pathway
Wang, H., Wang, X.-W., Zhou, G., Wang, W., Sun, Y.-G., Yang, S., & Fang, D.-C. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1253-4 · Cited by 20
Capello, D., & Gaïdano, G. (2009) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2009.018 · Cited by 23
Telomerase in hematologic malignancies
Bruedigam, C., & Lane, S. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000252 · Cited by 22
Nakamura, M., Hayashi, M., Konishi, H., Nunode, M., Ashihara, K., Sasaki, H., Terai, Y., & Ohmichi, M. (2020) · Oncology Letters · doi:10.3892/ol.2020.11344 · Cited by 22
Yokoyama, Y., Wan, X., Takahashi, Y., Shinohara, A., & Tamaya, T. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.9.853 · Cited by 23
Functional Link Between Myc and the Werner Gene in Tumorigenesis
Grandori, C., Robinson, K. L., Galloway, D. A., & Swisshelm, K. L. (2004) · Cell Cycle · doi:10.4161/cc.3.1.630 · Cited by 22
Self-citationAcidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells
Wang, X., Peihua, Z., Sun, X., Zheng, J., Wei, G., Zhang, L., Wang, H., Yao, J., Lu, S., & Jia, P. (2015) · Oncology Reports · doi:10.3892/or.2015.3908 · Cited by 19
MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers
Desi, N., Teh, V., Tong, Q. Y., Lim, C. Y., Tabatabaeian, H., Chew, X. H., Sánchez-Mejías, A., Chan, J. J., Zhang, B., Pitcheshwar, P., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02084-x · Cited by 19
Prasad, R. R., Mishra, D. K., Kumar, M., & Yadava, P. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08673 · Cited by 19
Carter, R., Mullassery, D., Sée, V., Theocharatos, S., Pizer, B. L., Losty, P. D., Jesudason, E. C., & Moss, D. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.24 · Cited by 19
Voglauer, R., Grillari, J., Fortschegger, K., Wieser, M., Sterovsky, T., Günsberg, P., Katinger, H. W. D., & Pfragner, R. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.961 · Cited by 21
Shen, H., Cheng, H., Chen, H., & Zhang, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5988 · Cited by 20
Robinson, N. J., Taylor, D. J., & Schiemann, W. P. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.15 · Cited by 20
Seo, E. J., Kim, H. J., Lee, C. J., Kang, H. T., & Hwang, E. S. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.03.041 · Cited by 22
Anticancer Therapy Targeting Telomeres and Telomerase: Current Status
Parkinson, E. K., & Minty, F. (2007) · BioDrugs · doi:10.2165/00063030-200721060-00005 · Cited by 22
Merle, P., Barraud, L., Lefrançois, L., Chevallier, M., Guérret, S., Maisonnas, M., Bordes, I., Savre‐Train, I., TREPO, C. G., & Vitvitski‐Trépo, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206375 · Cited by 19
Telomerase regulation: A key to inhibition?
Gómez, D. L. M., Fariña, H. G., & Gomez, D. E. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2104 · Cited by 22
Hsu, C.-C., Chen, C.-H., Hsu, T., Hung, J., Ko, J., Zhang, B., Lee, Y., Chen, H.-K., Chang, W., & Lin, D.-Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.12.004 · Cited by 18
Tianshengyuan-1 (TSY-1) regulates cellular Telomerase activity by methylation of TERT promoter
Yu, W., Qin, X., Jin, Y., Li, Y., Santiskulvong, C., Vu, V., Zeng, G., Zhang, Z., Chow, M., & Rao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13939 · Cited by 18
Telomerase Biogenesis and Activities from the Perspective of Its Direct Interacting Partners
Nguyen, K. T. T. T., & Wong, J. M. Y. (2020) · Cancers · doi:10.3390/cancers12061679 · Cited by 20
Potential Antiaging Effects of DLBS1649, a Centella asiatica Bioactive Extract
Karsono, A. H., Tandrasasmita, O. M., Berlian, G., & Tjandrawinata, R. R. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s299547 · Cited by 21
Telomerase as a novel and potentially selective target for cancer chemotherapy
Parkinson, E. K. (2003) · Annals of Medicine · doi:10.1080/07853890310006361 · Cited by 19
Chen, R., Zhu, J., Dong, Y. Q., He, C., & Hu, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5301 · Cited by 19
Cheng, D., Zhao, Y., Wang, S., Zhang, F., Russo, M., McMahon, S. B., & Zhu, J. (2016) · The FASEB Journal · doi:10.1096/fj.201601111r · Cited by 18
Siwicki, J. K., Hedberg, Y., Nowak, R., Lodén, M., Zhao, J., Landberg, G., & Roos, G. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00088-7 · Cited by 20
Matsumura‐Arioka, Y., Ohtani, K., Hara, T., Iwanaga, R., & Nakamura, M. (2004) · International Immunology · doi:10.1093/intimm/dxh201 · Cited by 19
Szutorisz, H., Palmqvist, R., Roos, G., Stenling, R., Schorderet, D. F., Reddel, R. R., Lingner, J., & Nabholz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204346 · Cited by 18
Self-citationTelomerase: Not Just Black and White, but Shades of Gray
Liu, J. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0203 · Cited by 20
Cassar, L., Nicholls, C., Pinto, A. R., Li, H., & Liu, J. (2009) · The FASEB Journal · doi:10.1096/fj.08-119529 · Cited by 18
RetractedTerra, M. L., Sant’Anna, T. B. F., de Barros, J. J. F., & Araujo, N. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072889 · Cited by 17
An Optimized Telomerase-Specific Lentivirus for Optical Imaging of Tumors
Yu, S., Yang, Y.-B., Liang, G., Li, C., Chen, L., Shi, C., Tang, X.-D., Li, C.-Z., Li, L., Wang, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3841 · Cited by 18
Jenkhetkan, W., Thitiorul, S., Jansom, C., & Ratanavalachai, T. (2017) · Mutagenesis · doi:10.1093/mutage/gex020 · Cited by 17
Assessment of telomerase as drug target in breast cancer
Jaiswal, R. K., & Yadava, P. K. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00045-2 · Cited by 17
Yan, S., Song, L., Chen, K., Yin, S., Peng, H., Cai, N., Ma, W., Songyang, Z., & Huang, Y. Y. (2022) · Cells · doi:10.3390/cells11091485 · Cited by 17
Zhang, Q., Feng, W., Wang, Q., Wang, J., Chai, L., Chen, Y., Wang, Y., Liu, J., Li, M., & Xie, X. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113233 · Cited by 17
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas
Shi, Z., Ge, X. Q., Li, M., Yin, J., Wang, X., Zhang, J., Chen, D., Li, X., Wang, X., Ji, J., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.024 · Cited by 17
Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network
Prochownik, E. V. (2022) · Cells · doi:10.3390/cells11243974 · Cited by 19
Akhlaghipour, I., Fanoodi, A., Zangouei, A. S., Taghehchian, N., Khalili‐Tanha, G., & Moghbeli, M. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10346-4 · Cited by 17
Guo, W., Li, L., He, Z.-Y., Zhang, Q., Liu, J., Cui-ying, H., Qin, F.-J., & Wang, T. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6363 · Cited by 17
Siwicki, J. K., Degerman, S., Chrzańowska, K., & Roos, G. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00140-x · Cited by 19
PTOP and TRF1 help enhance the radio resistance in breast cancer cell
Li, Z., Yang, X., Xia, N., Yang, L., Yu, H., Zhou, F., Conghua, X., & Zhou, Y. (2014) · Cancer Cell International · doi:10.1186/1475-2867-14-7 · Cited by 17
Zhang, Y.-L., Deng, C.-X., Zhou, W., Zhou, L.-Y., Cao, Q., Shen, W., Liang, H., & Chen, Z. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110820 · Cited by 17
Zou, L., Zhang, P., Luo, C., & Tu, Z. (2006) · Urology · doi:10.1016/j.urology.2005.12.029 · Cited by 17
Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma
Kunisada, M., Budiyanto, A., Bito, T., Nishigori, C., & Ueda, M. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06471x · Cited by 17
Angelica sinensis: A Chinese herb for brain cancer therapy
Lin, P., Liu, P.-Y., Lin, S., & Harn, H. (2012) · Biomedicine · doi:10.1016/j.biomed.2011.12.003 · Cited by 16
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
da Mota, T. H. A., Camargo, R., Biojone, E. R., Guimarães, A. F. R., Pittella-Silva, F., & de Oliveira, D. M. (2023) · Genes · doi:10.3390/genes14030691 · Cited by 18
Metadata
- Authors
- Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R.
- Affiliations
- Columbia University (US)
- Fred Hutch Cancer Center (US)
- ISREC Foundation (CH)
- Helmholtz Munich (DE)
- Venue
- Nature Genetics
- Published
- 1999-02
- Volume
- 21
- Issue
- 2
- Pages
- 220-224
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- DOI
- 10.1038/6010
- OpenAlex
- W1547608553
- Cited by
- 893
- References
- 30
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 25 · 2023: 20 · 2022: 24 · 2021: 24 · 2020: 28 · 2019: 21 · 2018: 21 · 2017: 27 · 2016: 31 · 2015: 33 · 2014: 28 · 2013: 26 · 2012: 28
- FWCI
- 32.25
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (5r01ca037165-17, 5r29ca075125-05)
- National Cancer Institute (CA-20525, CA37165, CA75125-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, telomerase reverse transcriptase, telomerase activation, transcriptional activation, MYC target genes, telomere length, chromosome integrity, cell proliferation, cell immortalization, carcinogenesis
- MeSH terms
- Proto-Oncogene Mas, Binding Sites, Cell Line, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proteins, RNA, Transcription, Genetic, Genes, myc, Proto-Oncogene Proteins c-myc, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.